ArticleCurrent cancer drug targets2024

Neuronatin Promotes the Progression of Non-small Cell Lung Cancer by Activating the NF-κB Signaling.

Huanwen Xiong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.